Disruptive Heart Assist Device by Procyrion

Universal Biotech
Procyrion, located in Houston, Texas was one of the laureates of 2015 Innovation Prize organized by Universal Biotech, subsidiary of Universal Medica Group. The start-up is developing Aortix™ a first-in-class circulatory assist device for ambulatory treatment of chronic heart failure. Heart failure affects over 6M people just in the US alone and around 600,000 new cases are diagnosed every year.

Read More